Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary to Age-related Macular Degeneration (AMD)”

234 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 234 results

Large-scale testing (Phase 3)Study completedNCT00473330
What this trial is testing

Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

Who this might be right for
Diabetes MellitusMacular Edema
Genentech, Inc. 377
Testing effectiveness (Phase 2)Looking for participantsNCT07215234
What this trial is testing

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy
Sanofi 104
Testing effectiveness (Phase 2)Ended earlyNCT05019521
What this trial is testing

Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Alexion Pharmaceuticals, Inc. 365
Not applicableStudy completedNCT05003258
What this trial is testing

Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Assiut University 25
Early research (Phase 1)Study completedNCT06006585
What this trial is testing

Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Who this might be right for
Geographic Atrophy
Boehringer Ingelheim 20
Not applicableStudy completedNCT01504074
What this trial is testing

Morphological and Functional Evaluation of Irvine-Gass Syndrome

Who this might be right for
Irvine Gass Syndrome
Medical University of Vienna 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05170048
What this trial is testing

Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry-AMD

Who this might be right for
Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
Evergreen Therapeutics, Inc. 90
Not applicableStudy completedNCT01566526
What this trial is testing

Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Oedema
Allergan 26
Not applicableStudy completedNCT07424235
What this trial is testing

Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data From a Natural History Cohort

Who this might be right for
Age Related Macular Degeneration (AMD)Age Related Macular DegenerationAMD+3 more
IRCCS Ospedale San Raffaele 60
Early research (Phase 1)Looking for participantsNCT03178149
What this trial is testing

The Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 42
Not applicableStudy completedNCT01571557
What this trial is testing

A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Allergan 573
Not applicableStudy completedNCT03370380
What this trial is testing

Aflibercept in Patients With Pigment Epithelial Detachments (PED)

Who this might be right for
Pigment Epithelial Detachment
University Hospital Muenster 18
Large-scale testing (Phase 3)Study completedNCT00150202
What this trial is testing

Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)

Who this might be right for
Macular Degeneration
Pfizer 90
Large-scale testing (Phase 3)Study completedNCT01012973
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein Occlusion
Bayer 177
Not applicableLooking for participantsNCT06662162
What this trial is testing

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationAge-related Macular Degeneration (ARMD)Intermediate AMD+1 more
i-Lumen Scientific AUS PTY LTD 100
Post-approval studies (Phase 4)Study completedNCT00976222
What this trial is testing

Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments

Who this might be right for
Pigment Epithelial Detachment
University Hospital Muenster 40
Testing effectiveness (Phase 2)Study completedNCT00284089
What this trial is testing

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)
Novartis 88
Large-scale testing (Phase 3)Looking for participantsNCT06541704
What this trial is testing

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Who this might be right for
Age-related Macular Degeneration (AMD)Geographic Atrophy (GA)
Regeneron Pharmaceuticals 975
Not applicableStudy completedNCT05196139
What this trial is testing

Visual Outcome After Vitrectomy With Subretinal tPA Injection

Who this might be right for
Age-Related Macular Degeneration
Universitaire Ziekenhuizen KU Leuven 96
Post-approval studies (Phase 4)Ended earlyNCT01795209
What this trial is testing

Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision

Who this might be right for
Branch Retinal Vein OcclusionMacular Edema
Seoul National University Bundang Hospital 19
Load More Results